Emcure Pharma

Rediff.com » News » Emcure Pharma

News for Emcure Pharma

News
Business

Ozempic launched in India, priced at Rs 2,200 per week

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Photograph: Tom Little/File......

'14+ Anti-Obesity Drugs In The Pipeline'

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent. IMAGE: Pens for the diabetes drug......

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with......

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

An expert panel of the Central Drugs Standard Control Organisation on Monday recommended granting permission to manufacture and market anti-Covid pill Molnupiravir for restricted emergency use for......

5 more manufacturers to produce black fungus drug: Govt

The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing......

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

It is one of 42 drug-making factories in India that the FDA has banned in recent years The US Food and Drug Administration (FDA) has warned Indian generic drugmaker Emcure Pharmaceuticals, saying......

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact on Indian exports, as it will affect only......

How Much Have MFs Invested In HDFC Bank?

With a deployment of Rs 2,720 crore in July, MFs' total investment in HDFC Bank in calendar year 2024 (till now) surged to Rs 48,820 crore. Photograph: Anushree Fadnavis/Reuters Mutual......

Actavis eyes Emcure unit, three others for buyout

Iceland's Actavis Pharma is in talks to acquire the pharma division of Pune-based Emcure Pharmaceuticals as part of its Indian business expansion plan.Emcure is among the four Indian companies......

Sun gets RBI nod for transfer of Ranbaxy overseas investments

Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of their......

Emcure Pharma

News for Emcure Pharma

Ozempic launched in India, priced at Rs 2,200 per week

'14+ Anti-Obesity Drugs In The Pipeline'

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

5 more manufacturers to produce black fungus drug: Govt

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

How Much Have MFs Invested In HDFC Bank?

Actavis eyes Emcure unit, three others for buyout

Sun gets RBI nod for transfer of Ranbaxy overseas investments

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS